Beike Reports Successful Test of Stem Cell Treatment for Lupus

In a new study, an umbilical cord mesenchymal stem cells transplant (UC-MSCT) seemed to improve patients with systemic lupus erythematosus (SLE) who had not responded to standard treatments. Among the16 patients who received stem cell transplants, there were no treatment-related mortality or other adverse events. Ten patients completed at least 6 months of follow-up and 2 patients were followed for more than 2 years. More details...